Yusuf Akbaba

730 total citations
18 papers, 679 citations indexed

About

Yusuf Akbaba is a scholar working on Organic Chemistry, Molecular Biology and Process Chemistry and Technology. According to data from OpenAlex, Yusuf Akbaba has authored 18 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Process Chemistry and Technology. Recurrent topics in Yusuf Akbaba's work include Enzyme function and inhibition (7 papers), Synthesis and Catalytic Reactions (7 papers) and Carbon dioxide utilization in catalysis (4 papers). Yusuf Akbaba is often cited by papers focused on Enzyme function and inhibition (7 papers), Synthesis and Catalytic Reactions (7 papers) and Carbon dioxide utilization in catalysis (4 papers). Yusuf Akbaba collaborates with scholars based in Türkiye, Italy and Saudi Arabia. Yusuf Akbaba's co-authors include Süleyman Göksu, İlhami Gülçın, Akın Akıncıoğlu, Claudiu T. Supuran, Hülya Göçer, Abdullah Menzek, Ertan Şahi̇n, Halis Türker Balaydın, Ali Naderi and Pınar Kalın and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Tetrahedron and Bioorganic & Medicinal Chemistry.

In The Last Decade

Yusuf Akbaba

16 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuf Akbaba Türkiye 10 541 379 350 64 31 18 679
Halis Türker Balaydın Türkiye 13 388 0.7× 295 0.8× 349 1.0× 79 1.2× 53 1.7× 17 639
Arleta Rifati Nixha Kosovo 10 258 0.5× 138 0.4× 197 0.6× 26 0.4× 39 1.3× 17 416
Oktay Talaz Türkiye 14 319 0.6× 152 0.4× 358 1.0× 70 1.1× 11 0.4× 17 634
Bünyamin Özgeriş Türkiye 9 366 0.7× 260 0.7× 284 0.8× 19 0.3× 40 1.3× 19 529
Ufuk Atmaca Türkiye 11 308 0.6× 216 0.6× 240 0.7× 25 0.4× 32 1.0× 24 439
Özcan Güleç Türkiye 8 211 0.4× 111 0.3× 182 0.5× 18 0.3× 49 1.6× 15 393
Hatice Esra Duran Türkiye 9 244 0.5× 136 0.4× 179 0.5× 13 0.2× 45 1.5× 26 429
Kaan Küçükoğlu Türkiye 12 348 0.6× 181 0.5× 346 1.0× 38 0.6× 36 1.2× 31 541
Emin Garibov Azerbaijan 7 321 0.6× 235 0.6× 244 0.7× 11 0.2× 32 1.0× 10 429
Mehtap Tugrak Türkiye 14 480 0.9× 261 0.7× 465 1.3× 35 0.5× 49 1.6× 24 664

Countries citing papers authored by Yusuf Akbaba

Since Specialization
Citations

This map shows the geographic impact of Yusuf Akbaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuf Akbaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuf Akbaba more than expected).

Fields of papers citing papers by Yusuf Akbaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuf Akbaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuf Akbaba. The network helps show where Yusuf Akbaba may publish in the future.

Co-authorship network of co-authors of Yusuf Akbaba

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuf Akbaba. A scholar is included among the top collaborators of Yusuf Akbaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuf Akbaba. Yusuf Akbaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Akbaba, Yusuf, et al.. (2024). Synthesis of β-lactams and transformation to β-amino acid ethyl ester derivatives: Theoretical calculations. Tetrahedron. 167. 134247–134247. 2 indexed citations
2.
Akıncıoğlu, Akın, Yusuf Akbaba, Leyla Polat Köse, & Süleyman Göksu. (2023). An Insight into the Asymmetric Resolution of 1‐Aminoindane Derivatives. ChemistrySelect. 8(17).
3.
Akbaba, Yusuf, et al.. (2023). Novel tetrahydronaphthalen-1-yl-phenethyl ureas: synthesis and dual antibacterial-anticancer activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2286925–2286925. 2 indexed citations
4.
Akıncıoğlu, Akın, et al.. (2023). Synthesis and asymmetric resolution of substituted 2-aminoindane and 2-aminotetralin derivatives. Tetrahedron. 133. 133277–133277. 4 indexed citations
5.
6.
7.
Özgeriş, Bünyamin, Yusuf Akbaba, Özlem Özdemir Tozlu, Hasan Türkez, & Süleyman Göksu. (2017). Synthesis and Anticancer Activity of Novel Ureas and Sulfamides Incorporating 1-Aminotetralins. Archives of Medical Research. 48(6). 513–519. 16 indexed citations
8.
Akbaba, Yusuf, Bünyamin Özgeriş, Leyla Polat Köse, et al.. (2016). Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(6). 1484–1491. 49 indexed citations
9.
Akbaba, Yusuf, Süleyman Göksu, Ertan Şahi̇n, Hamdullah Kılıç, & Hasan Seçen. (2016). Synthesis and asymmetric resolution of a dopaminergic compound: 2-amino-5-methoxyindane. Tetrahedron Asymmetry. 27(11-12). 475–479. 2 indexed citations
10.
Akbaba, Yusuf, et al.. (2014). Synthesis and Carbonic Anhydrase Inhibitory Effects of Novel Sulfamides Derived from 1‐Aminoindanes and Anilines. Archiv der Pharmazie. 347(12). 950–957. 84 indexed citations
11.
Göksu, Süleyman, Ali Naderi, Yusuf Akbaba, et al.. (2014). Carbonic anhydrase inhibitory properties of novel benzylsulfamides using molecular modeling and experimental studies. Bioorganic Chemistry. 56. 75–82. 121 indexed citations
12.
Akbaba, Yusuf, Halis Türker Balaydın, Abdullah Menzek, et al.. (2013). Synthesis and Biological Evaluation of Novel Bromophenol Derivatives as Carbonic Anhydrase Inhibitors. Archiv der Pharmazie. 346(6). 447–454. 42 indexed citations
13.
Akıncıoğlu, Akın, Yusuf Akbaba, Hülya Göçer, et al.. (2013). Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors. Bioorganic & Medicinal Chemistry. 21(6). 1379–1385. 116 indexed citations
14.
Akbaba, Yusuf, Akın Akıncıoğlu, Hülya Göçer, et al.. (2013). Carbonic anhydrase inhibitory properties of novel sulfonamide derivatives of aminoindanes and aminotetralins. Journal of Enzyme Inhibition and Medicinal Chemistry. 29(1). 35–42. 120 indexed citations
15.
Akbaba, Yusuf, Cüneyt Türkeş, Hakan Söyüt, et al.. (2012). Synthesis and paroxonase activities of novel bromophenols. Journal of Enzyme Inhibition and Medicinal Chemistry. 28(5). 1073–1079. 53 indexed citations
16.
Akbaba, Yusuf, Halis Türker Balaydın, Süleyman Göksu, Ertan Şahi̇n, & Abdullah Menzek. (2010). Total Synthesis of the Biologically Active, Naturally Occurring 3,4‐Dibromo‐5‐[2‐bromo‐3,4‐dihydroxy‐6‐(methoxymethyl)benzyl]benzene‐1,2‐diol and Regioselective O‐Demethylation of Aryl Methyl Ethers. Helvetica Chimica Acta. 93(6). 1127–1135. 37 indexed citations
17.
Menzek, Abdullah, Halis Türker Balaydın, Yusuf Akbaba, Ertan Şahi̇n, & Süleyman Göksu. (2010). First and short syntheses of biologically active, naturally occurring brominated mono- and dibenzyl phenols. ARKIVOC. 2009(14). 75–87. 20 indexed citations
18.
Çelebisoy, Neşe, Zafer Çolakoğlu, Yusuf Akbaba, & Nur Yüceyar. (1998). Continuous muscle fibre activity: a case treated with acetazolamide. Journal of Neurology Neurosurgery & Psychiatry. 64(2). 256–258. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026